HIV-associated parkinsonism reversed with antiretroviral therapy

Yu-Wen Cheng; Chin-Hsien Lin; Ruey-Meei Wu
June 2014
Neurology Asia;Jun2014, Vol. 19 Issue 2, p199
Academic Journal
Human immunodeficiency virus (HIV) infection can cause variable movement disorders, including parkinsonism. HIV-related parkinsonism usually responds well to highly-active antiretroviral therapy (HAART), suggesting a possible reversible dysfunction of the dopaminergic system. We report the case of a 42-year-old man who presented with rapidly progressive symmetric parkinsonism, cognitive decline, and loss of postural reflex as the initial manifestation of HIV infection. A significant improvement of his parkinsonism after HAART demonstrates a potentially reversible dopaminergic system dysfunction secondary to HIV infection. A normal 99mTc-TRODAT-1 SPECT image after HAART treatment paralleled the clinical improvement in extrapyramidal symptoms. Early identification of HIV-related parkinsonism, especially in patients with symmetrical akinetic-rigidity and early loss of posture reflex, is important for its potential reversibility with HAART therapy.


Related Articles

  • CME/CE Dermatology Clinic. Purple trunk plaques on a homosexual man. Malakouti, Navid; Nunley, Julia R. // Clinical Advisor;May2013, Vol. 16 Issue 5, p67 

    The article presents a case study of a 35-year-old white man seeking treatment for a rash of several weeks' duration. A punch biopsy was undertaken and he was diagnosed to be suffering from Kaposi sarcoma (KS), an AIDS-defining illness in an HIV-positive individual. The patient was treated with...

  • Clinical Profiles of HIV-Infected, HAART-Naive Patients Admitted to a Tertiary Level Hospital in Maseru, Lesotho. Thinyane, K.; Cooper, V. // Internet Journal of Infectious Diseases;2013, Vol. 11 Issue 1, p1 

    Introduction: Southern Africa has one of the highest HIV prevalence rates globally. The HIV epidemic in the region is characterised by high rates of morbidity and mortality. The aim of this study was to document the clinical profiles of patients hospitalised for the treatment of HIV-related...

  • The Influence of HAART on CMV Retinitis. Shechtman, Diana L. // Review of Optometry;11/15/2006 Part 2 of 2, Vol. 143, p8 

    The article focuses on the impact of highly active anti-retroviral therapy (HAART) on HIV patients with cytomegalovirus (CMV) retinitis in the U.S. This alternative treatment reduced the prevalence of the CMV disease and decreased mortality rate of patients suffering from an HIV complication....

  • Immune reconstitution inflammatory syndrome after initiating highly active antiretroviral therapy in HIV-infected children. Kilborn, Tracy; Zampoli, Marco // Pediatric Radiology;Jun2009, Vol. 39 Issue 6, p569 

    The outcome of HIV infection has improved since the widespread availability of highly active antiretroviral therapy (HAART). Some patients, however, develop a clinical and radiological deterioration following initiation of HAART due to either the unmasking of occult subclinical infection or an...

  • Usefulness of hemoglobin and albumin as prognostic markers for highly active antiretroviral therapy for HIV-1 infection. CHAUHAN, NEERAJ K.; VAJPAYEE, MADHU; SINGH, ALPANA // Indian Journal of Medical Sciences;Jul2011, Vol. 65 Issue 7, p286 

    Background: Usefulness of hemoglobin and albumin as prognostic markers for highly active anti-retroviral therapy for HIV-1 infection.Introduction: Anemia and hypoalbuminemia are common complications in human immunodeficiency virus (HIV) infection. We aimed to...

  • Cerebrovascular disease in HIV-infected individuals in the era of highly active antiretroviral therapy. Cruse, Belinda; Cysique, Lucette; Markus, Romesh; Brew, Bruce // Journal of NeuroVirology;Aug2012, Vol. 18 Issue 4, p264 

    The widespread use of highly active antiretroviral therapy (HAART) in HIV-infected individuals mostly in developed countries has dramatically improved their prognosis. In such advantaged regions of the world, therefore, many patients are now transitioning from middle into older age, with altered...

  • Hepatotoxicity of antiretroviral therapy. Olczak, Anita; GrÄ…bczewska, Edyta; Karwowska, Kornelia // Gastroenterologia Polska / Gastroenterology;2009, Vol. 16 Issue 4, p301 

    Introduction: Highly active antiretroviral therapy has changed the live expectancy of persons living with HIV. An important complication is drug induced hepatotoxicity. The aim of this retrospective study was to investigate the prevalence and risk factors for liver enzyme elevation following the...

  • ART imitates life: the puzzle of HIV, ageing and antiretroviral treatment. Hoy, Jennifer; Vujovic, Olga // HIV Australia;2009, Vol. 8 Issue 3, p20 

    The article discusses the treatment of HIV and age-related HIV infection with the use of antiretroviral therapy. It refers to a SMART study which found out that it does not only prevent HIV-related opportunistic infection but also in non-AIDS complications including heart disease, cancer, and...

  • Noninfectious complications in HIV disease: Need for rational changes in HIV disease management in the highly active antiretroviral therapy era. Ramana, K. V.; Rao, Ratna // Annals of Tropical Medicine & Public Health;May/Jun2013, Vol. 6 Issue 3, p383 

    A letter to the editor is presented on noninfectious complications in HIV disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics